Five rules for evaluating melanonychia

WAIKOLOA, HAWAII – Any dermatologist can master punch biopsy of the matrix, according to a nail disease expert.

Derm MOC reboot welcomed

WAIKOLOA, HAWAII – Criticisms prompt major overhaul of the dermatology Maintenance of Certification process.

Onychomycosis that fails terbinafine probably isn’t T. rubrum

WAIKOLOA, HAWAII – T. rubrum remains the most common cause of toenail fungus in the United States, but nondermatophyte molds are on the rise.

Staying up to date on screening may cut risk of death from CRC

Staying up to date on screening was associated with a 62% decrease in the odds of dying from colorectal cancer.

Expert Q&A: What’s new in alopecia areata research and treatment?

LAS VEGAS – Dr. Maria Hordinsky addresses treatment issues and more, in an interview at the Las Vegas Dermatology Seminar.

Invasive strategy increased bleeding risk in frail older AMI patients

Registry analysis suggests frailty in an AMI patient calls for personalized decision making.

HCV antibodies linked to poorer cardiac outcomes in ACHD patients

Adults with congenital heart disease and HCV antibody positivity had significantly worse cardiac outcomes.

Quality of life with PAD follows function, not clinical markers

Patients with symptomatic PAD rate their health-related quality of life based on functional capabilities, not markers of disease severity or comorbidities.

Higher prenatal exposure to daylight tied to lower depression risk

Exposure and birth in northern latitudes conferred a 7% risk for lifetime depression, compared with southern latitudes, where risk increased to 15%.

Questions, documentation, and lab tests are crucial in alopecia areata

LAS VEGAS – Alopecia areata affects an estimated 1.7%-2.1% of the population and is sporadic in 50%-80% of cases.

Pages